» Articles » PMID: 25932326

Cognitive Dysfunction in Severe Chronic Obstructive Pulmonary Disease (COPD) with or Without Long-Term Oxygen Therapy (LTOT)

Overview
Specialty Pulmonary Medicine
Date 2015 May 2
PMID 25932326
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory condition which can lead to comorbidities of variable severity, cognitive dysfunction included. The role of supplemental oxygen in preventing COPD-induced cognitive deterioration is still debated, but only episodically investigated. The aim of this study was to compare the cognitive pattern of hypoxemic COPD subjects treated with long-term oxygen (LTOT) to that of patients of comparable severity assuming oxygen on irregular basis, and to normal reference values.

Methods: Lung function, arterial blood gases, health status, and cognitive function measured by means of four psychometric tests focusing different domains of cognition (such as: MMSE, Clock test; TMT-A; TMT-B) were assessed in 146 well matched hypoxemic COPD patients (males n = 96, 66%; mean age = 70.5 ± 12.9). Seventy-three patients were assuming long-term oxygen (LTOT), while the remaining seventy-three were only using oxygen as needed (AN). Regarding statistics, t test and ANOVA (Duncan test) were used to analyze data, assuming a p < 0.05 as the lowest limit of significance.

Results: Even though all COPD patients showed a poorer psychometric profile vs corresponding normal reference values, LTOT patients showed a lower prevalence of severe deterioration in cognition. Also the extent of impairment was significantly lower in these patients when assessed by TMT-A and TMT-B (p < 0.012 and 0.001, respectively), but not when measured by MMSE and Clock test (both p = ns). Several domains of cognition are variably affected by persistent hypoxemia in COPD patients. A panel of psychometric tools is needed for identifying the pattern of cognitive dysfunctions in these patients. Memory and attention (functions assessed by MMSE and Clock test) are only mildly-moderately affected, while visual processing, reproduction of numeric sequences, cognition flexibility, and shifting capacity (functions assessed by TMT-A and TMT-B) are much more deteriorated (p < 0.012 and p < 0.001, respectively).

Conclusions: Only LTOT allows to preserve significantly (p < 0.022) cognitive functions from the COPD-induced deterioration. This assumption is of strategic value for COPD patients who are prescribed long-term oxygen because they frequently are not aware of the cognitive risks related to their condition.

Citing Articles

Health and Economic Impact of Different Long-Term Oxygen Therapeutic Strategies in Patients with Chronic Respiratory Failure: A French Nationwide Health Claims Database (SNDS) Study.

Glezer S, Mercier G, Coursier J, Petrica N, Pini M, Pg A Pulm Ther. 2024; 10(2):237-262.

PMID: 38822956 PMC: 11282007. DOI: 10.1007/s41030-024-00259-x.


Roles of Omega-3 Polyunsaturated Fatty Acids in Managing Cognitive Impairment in Chronic Obstructive Pulmonary Disease: A Review.

Zailani H, Satyanarayanan S, Liao W, Hsu Y, Huang S, Galecki P Nutrients. 2023; 15(20).

PMID: 37892438 PMC: 10609799. DOI: 10.3390/nu15204363.


Preliminary study of assessing cognitive impairment in older patients with chronic obstructive pulmonary disease by using a cognitive functional assessment tool via a touchscreen personal computer.

Ogawa M, Uchiumi A, Sato S, Hamakawa Y, Kobashi M, Aoyama T Multidiscip Respir Med. 2023; 18:892.

PMID: 36798953 PMC: 9926919. DOI: 10.4081/mrm.2023.892.


Association of chronic obstructive pulmonary disease with mild cognitive impairment and dementia risk: A systematic review and meta-analysis.

Zhao L, Zhou X World J Clin Cases. 2022; 10(11):3449-3460.

PMID: 35611207 PMC: 9048565. DOI: 10.12998/wjcc.v10.i11.3449.


Shared Molecular Mechanisms among Alzheimer's Disease, Neurovascular Unit Dysfunction and Vascular Risk Factors: A Narrative Review.

Falsetti L, Viticchi G, Zaccone V, Guerrieri E, Moroncini G, Luzzi S Biomedicines. 2022; 10(2).

PMID: 35203654 PMC: 8962428. DOI: 10.3390/biomedicines10020439.


References
1.
Ait-Khaled N, Enarson D, Ottmani S, El Sony A, Eltigani M, Sepulveda R . Chronic airflow limitation in developing countries: burden and priorities. Int J Chron Obstruct Pulmon Dis. 2007; 2(2):141-50. PMC: 2695613. View

2.
Kuller L, Ockene J, Townsend M, Browner W, Meilahn E, Wentworth D . The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trial. Am Rev Respir Dis. 1989; 140(3 Pt 2):S76-81. DOI: 10.1164/ajrccm/140.3_Pt_2.S76. View

3.
Anstey K, Windsor T, Jorm A, Christensen H, Rodgers B . Association of pulmonary function with cognitive performance in early, middle and late adulthood. Gerontology. 2004; 50(4):230-4. DOI: 10.1159/000078352. View

4.
Dodd J, Getov S, Jones P . Cognitive function in COPD. Eur Respir J. 2010; 35(4):913-22. DOI: 10.1183/09031936.00125109. View

5.
Jones P, Harding G, Berry P, Wiklund I, Chen W, Leidy N . Development and first validation of the COPD Assessment Test. Eur Respir J. 2009; 34(3):648-54. DOI: 10.1183/09031936.00102509. View